Navigation Links
Managing Myeloma Website Announces Fellow Scholarship Program to Attend and Report on Annual American Society of Hematology in New Orleans
Date:10/15/2009

MORRISVILLE, Pa., Oct. 15 /PRNewswire/ -- Managing Myeloma (www.ManagingMyeloma.com), an accredited multi-supported educational website for multidisciplinary professionals, announces the opportunity for fellows in oncology to win a scholarship to attend the December 2009 American Society of Hematology Annual Meeting in New Orleans, Louisiana. The scholarship includes registration fees, airfare, hotel accommodations, and a per diem for meals.

During the conference, the scholarship winners will participate in an information gathering and reporting activity based on identified poster and oral sessions relevant to multiple myeloma. The articles generated will be published on the Managing Myeloma website.

"The Managing Myeloma Scholarship Program is a great opportunity for fellows to learn more about multiple myeloma, meet colleagues, hold discussions with leading myeloma experts and have their summaries of poster and oral sessions from the conference published to benefit the community of practicing physicians, pharmacists, and nurses not in attendance at this prestigious scientific meeting," said Sheri Sturgis, chief operating officer of MediCom Worldwide, the accredited developer of the Managing Myeloma site.

To apply for the scholarship, fellows must submit a statement summarizing relevant experience or specific interest in multiple myeloma, a brief biography, and a reference from their program director or mentor. Those interested in applying for the program can contact MediCom project manager Megan Kilmer at mkilmer@medicaled.com or call 800-408-4242, ext. 133.

About MediCom Worldwide

MediCom Worldwide is accredited by the Accreditation Council for Continuing Medical Education as a provider of continuing medical education for physicians; is accredited by th
'/>"/>

SOURCE MediCom Worldwide
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Medical Travel Company Satori World Medical Announces Relationship with Managing General Underwriter GreenWood International Insurance Services (GWI)
2. Mayo Clinic Health Manager Now Includes Features for People Managing Hypertension and High Cholesterol
3. Family Circle Magazine Features AmLactin(R) in Article on Managing Dry Skin Associated With Keratosis Pilaris
4. Managing Myeloma Website Launches an Interactive Forum for Oncology Nurses, Wins 2009 Gold Hermes Creative Award for Site Overall
5. iCRco Releases Clarity PACS, a New Approach to Managing Digital Imaging Data
6. As Medical Bills Contribute to 50% of U.S. Foreclosures, CreditFYI Shares 5 Tactics for Managing Medical Debt
7. Cardiac CT is more cost effective when managing low-risk patients with chest pain
8. Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health
9. Lumension Audiocast With Aberdeen Group Highlights How to Reduce IT Costs By Effectively Managing and Securing Endpoints
10. Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support
11. New System for Managing Sleep Disorders Aims to Improve Sleep Through Brain Chemistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Sika Sarnafil , the worldwide market leader in ... Systems of Iowa as the Recycling Project of the ... the re-roofing of the SuperTarget retail store in Olathe, ... contractor and one of Target’s Preferred Tier One roofing ... building practices and they are a worthy recipient of ...
(Date:5/23/2013)... Professional Insurance Plans, an independent insurance ... celebrate Fibromyalgia Education and Awareness Month. As a ... country, the agency feels that it is important for ... that affects an estimated 10 million of Americans. , ... definition of Fibromyalgia (FM) is, “a common and complex ...
(Date:5/23/2013)... 23, 2013 Traditionally, laser skin therapy ... on skins of colour, this can be tricky. Based ... 1-1V may be treated safely with most lasers. Darker ... discoloration issues, have been left without recourse. Those who ... “clear” their skin successfully. , Hyperpigmentation occurs ...
(Date:5/23/2013)... , , THURSDAY, May 23 (HealthDay News) -- Statins are ... but the medications also could hamper heart patients, ability ... A small group of overweight or obese people ... taking a 40 milligram daily dose of simvastatin, while ... same exercise regimen did show improvement, found the study ...
(Date:5/23/2013)... PTSD , Soldiers returning home from combat may ... disorder if public support for a war effort is ... shapes the level of distress soldiers feel from the ... two experiments that asked participants to exterminate woodlice in ... actor show either interest or disgust for the act ...
Breaking Medicine News(10 mins):Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 3Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3
... Spanish . , The PhD, defended ... the Basque Country, proposes a series of recommendations that ... professionals who treat terminal cancer patients. , Autonomy is ... armed with knowledge about the causes of the illness, ...
... talk and ... care about digestive health, WHITE PLAINS, ... advertising campaign for Activia featuring award-winning,actress and passionate self-esteem advocate ... air throughout 2008, Curtis draws attention,to the importance of digestive ...
... Named National, Spokesperson for The Leukemia & Lymphoma Society,s 2008 Light The ... ... March 3 Rob Brown, who stars in the,upcoming drama The Express as ... to win the Heisman,Trophy, is the national spokesperson for The Leukemia & Lymphoma ...
... The Providence Service,Corporation (Nasdaq: PRSC ) today ... its fourth quarter and year ended December 31, 2007,on ... Providence will hold a conference call at 11:00 a.m. ... Thursday, March 13, 2008 to discuss its,financial results and ...
... CEL-SCI CORPORATION,(Amex: CVM ) provided details ... groundbreaking activities currently underway at its,manufacturing facility near ... Multikine(R), the Company,s lead compound, for a pivotal,Phase ... untreated head,and neck cancer patients. The facility, which ...
... ... Hospitals, TEL AVIV, ... digital templating software, will,launch its unique Orthoweb on-line service at the ... in San,Francisco (Booth #349, Hall A)., "This is a real ...
Cached Medicine News:Health News:Factors that enhance autonomy of cancer patients 2Health News:Factors that enhance autonomy of cancer patients 3Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 2Health News:Dannon Activia Launches Thought-Provoking Advertising Campaign Featuring Jamie Lee Curtis 3Health News:Actor Rob Brown Rushes to Gain Ground Against Blood Cancer 2Health News:Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes 2Health News:Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes 3Health News:CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial 2Health News:Orthocrat to Launch On-Line Service for Storing and Sharing Pre-Operative Data at AAOS 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Bionovo, Inc. (Nasdaq: BNVI, BNVID), a drug discovery and development ... oncology, today announced that Dr. Isaac Cohen, O.M.D., Chairman and ... Healthcare Conference at 4:00 p.m. ET on Tuesday, September 28, ... Palace hotel in New York City. Interested parties ...
... Sept. 21 Anthera Pharmaceuticals, Inc. (Nasdaq: ... definitive agreements with certain accredited investors in connection with ... Section 4(2) of the Securities Act of 1933, as ... of the transaction, Anthera will receive gross proceeds of ...
Cached Medicine Technology:Bionovo to Present at the JMP Securities Healthcare Conference 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 3Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 4
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... coated with a thin layer ... the surface slick as glass ... prevent debris from collecting on ... For partial stenosis. Silicone with ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: